Search Results - pierre+coulombe

1 Results Sort By:
C10069: Treatment of Epidermolysis Bullosa Simplex and Related Diseases
Value Proposition: Advantages: • Uses known natural chemicals to effectively prevent or diminish skin blistering • Represents a safe, effective, and affordable therapy • Has a wider application as the basis for a therapy of keratin-based diseases Technical Details: Epidermolysis bullosa is a disorder characterized by the presence of extremely...
Published: 6/27/2024   |   Inventor(s): Michelle Kerns, Pierre Coulombe
Keywords(s): Agonists/Promoters, Disease Indication, Epidermolysis Bullosa Simplex, Non-novel, Predicted Novelty, Skin Disorders, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Dermatology, Clinical and Disease Specializations > Genetic Diseases > Epidermolysis Bullosa Simplex, Clinical and Disease Specializations > Rare Diseases, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Genetic Diseases, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum